-$27.62 (-6.78%)
Industry, Sector & symbol
| Stock Exchange | NASDAQ |
| CEO | David J. Rosa |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Current Symbol | ISRG |
| CUSIP | 46120E602 |
| CIK | 0001035267 |
| Web | https://www.intuitive.com |
| Phone | 408 523 2100 |
| Currency | USD |
| Employees | 17021 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | 0.00 |
| Payout Ratio | 0.00 |
| Current Ratio | 6.03 |
| Quick Ratio | 5.01 |
| Cash Ratio | 1.07 |
Sales & Book Value
| Annual Sales | $10.06B |
| Price / Sales | 12.70 |
| Cash Flow | 7.99 |
| Price / Cash Flow | 47.42 |
| Price / Book | 7.71 |
Price Target and Rating
| Average Stock Price Forecast | $575.00 |
| High Stock Price Forecast | $750.00 |
| Low Stock Price Forecast | $430.00 |
| Forecast Upside/Downside | -34.00% |
| Consensus Rating | Neutral |
| Rating Score(0-5) | 3 |
| Research Coverage | 55 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $7.87 |
| Trailing P/E Ratio | 45.34 |
| PEG Ratio | 2.20 |
| P/E Growth | 2.20 |
| Net Income | $2.86B |
| Net Margin | 28.15% |
| Pretax Margin | 33.86% |
| Return on Equity | 17.01% |
| Return on Assets | 14.81% |
Financials Score
| AltmanZ Score | 36.55 |
| Piotroski Score | 8.00 |
| Working Capital | 9.61B |
| Total Assets | 20.11B |
| Ebit | 3.58B |
| Market Cap | 144.19B |
| Total Liabilities | 2.51B |
About Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock
Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, a ... nd essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.
Goldman Sachs Says the Crowd Is Wrong on This Beaten-Down Medical Robotics Giant
2026-07-15 00:15:00
Despite Intuitive Surgical's near-term headwinds, one analyst thinks the stock could soar from current levels. The company's ongoing efforts could pay off eventually as it rides the underpenetrated robotic surgery market.
Here's Exactly Why Intuitive Surgical Stock Is Floundering in 2026
2026-07-14 16:15:00
Intuitive Surgical's stock has fallen by more than 25% so far in 2026. The stock is off by more than 30% from its 52-week high.
Intuitive Surgical Pre-Q2 Analysis: Buy, Hold or Sell the Stock Now?
2026-07-14 10:56:33
Intuitive Surgical heads into Q2 earnings with strong procedure momentum, da Vinci 5 adoption and expectations for another earnings beat despite margin pressures.
Buy 3 AI-Led Medical Devices Laggards of 1H Set to Gather Pace in 2H
2026-07-14 08:41:07
ISRG, IDXX and ALC are three AI-driven medical device laggards with strong business momentum and improving earnings estimates for a potential 2H rebound.
Buy 5 Large-Cap Stocks With Extensive Robotics Applications for 2H 2026
2026-07-13 09:25:20
Buy 5 large-cap robotics stocks, ISRG, TER, CDNS, MCHP and FTV for 2H 2026 supported by AI, automation and expanding robotics applications.
Intuitive Surgical Has +35% Upside: A Compelling Buy Story Before July 16
2026-07-13 08:00:22
Intuitive Surgical (NASDAQ:ISRG | ISRG Price Prediction) looks compelling ahead of its July 16 earnings report, and the setup rarely gets this clean for a category leader trading well below fair value.
Breakfast News: Can Netflix's Ads Fuel a Rebound?
2026-07-13 07:30:00
Netflix and banks kick off earnings season, markets start the week shaky, and more
2026-07-13 01:41:32
Intuitive Surgical, Inc. (NASDAQ:ISRG) will release its second quarter earnings report after the closing bell on Thursday, July 16.
Frequently Asked Questions
What is the current Intuitive Surgical, Inc. (ISRG) stock price?
Intuitive Surgical, Inc.(NASDAQ:ISRG) stock price is $379.5 in the last trading session. During the trading session, ISRG stock reached the peak price of $603.88 while $378.5 was the lowest point it dropped to. The percentage change in ISRG stock occurred in the recent session was --6.78% while the dollar amount for the price change in ISRG stock was -$-27.62.
ISRG's industry and sector of operation?
The NASDAQ listed ISRG is part of Medical - Devices industry that operates in the broader Healthcare sector.
Who are the executives of ISRG?
Mark Brosius
| Executive VP and Chief Manufacturing & Supply Chain Officer
Gary Loeb
| Executive Vice President and Chief Legal & Compliance Officer
Henry L. Charlton
| Senior VP of Global Business Operations
Jason Hart
| Senior Vice President of Global Marketing
Federico Barbagli
| Senior VP & GM of Endoluminal
How many employees does ISRG have?
Number of ISRG employees currently stands at 17021. ISRG operates from 1020 Kifer Road, Sunnyvale, CA 94086-5304, US.
Link for ISRG official website?
Official Website of ISRG is: https://www.intuitive.com
How do I contact ISRG?
ISRG could be contacted at phone #408 523 2100 and can also be accessed through its website. ISRG operates from 1020 Kifer Road, Sunnyvale, CA 94086-5304, US.
How many shares of ISRG are traded daily?
The average number of ISRG shares traded daily for last 3 months was 2.45M.
What is the market cap of ISRG currently?
The market value of ISRG currently stands at $134.4B with its latest stock price at $379.5